<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>16759616</identifier>
<setSpec>0212-6982</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Gambí Pisonero, N</dc:author>
<dc:author>González-Lahoz, J</dc:author>
<dc:author>del Val Gómez Martínez, M</dc:author>
<dc:author>González Gallardo, F</dc:author>
<dc:author>Castilla Miguel, S</dc:author>
<dc:author>García Benayas, T</dc:author>
<dc:author>Torres Isidro, M V</dc:author>
<dc:author>Gallego Sanz, D</dc:author>
<dc:description xml:lang="en">It is reported a HIV infected patient under antiretroviral therapy including tenofovir therapy who was referred to the Nuclear Medicine Department to complete bone pain study. A bone scan was performed at 3 hours after the injection of 740 MBq of 99mTc-MDP, revealing an abnormal distribution with characteristic changes compatible with osteomalacia. In further analysis, a secondary hyperparathyroidism and osteomalacia were diagnosed in the context of Fanconi syndrome, an infrequent complication described in patients under treatment with tenofovir.</dc:description>
<dc:type>Case Reports</dc:type>
<dc:language>es</dc:language>
<dc:date>2006 Mar-Apr </dc:date>
<dc:title xml:lang="es">Utilidad de la gammagrafía ósea en el diagnóstico de osteomalacia secundaria en un paciente en tratamiento con tenofovir.</dc:title>
<dc:title xml:lang="en">[Role of bone gammagraphy in the diagnosis of secondary osteomalacia in a patient treated with tenofovir].</dc:title>
<dc:publisher>Revista espanola de medicina nuclear</dc:publisher>
</metadata>
</record>
</pubmed-document>
